# Unveiling the Silent Threat: The Rise of Β-Lactamase Enzymes in Gram-Negative Bacterial Isolates Identified From Sterile Body Fluids in an Indian Healthcare Institution

## TL;DR

This study examines the rise of antibiotic-resistant gram-negative bacteria in sterile body fluids at an Indian hospital, emphasizing the need for better diagnostics and treatment strategies.

## Contribution

The study provides current data on β-lactamase-producing bacteria in sterile fluids, focusing on resistance patterns in a vulnerable patient population.

## Key findings

- 15% of sterile body fluid samples showed bacterial growth, with E. coli and P. aeruginosa being the most common isolates.
- Over 40% of gram-negative isolates produced ESBL, and nearly 48% produced MBL, indicating high resistance levels.
- CSF samples showed the highest resistance rates, highlighting the need for rapid diagnostics in critical cases.

## Abstract

Background

Bacterial infections in sterile body fluids represent a significant clinical concern, particularly when caused by resistant pathogens. β-lactamase-producing gram-negative bacteria, including extended-spectrum-lactamase (ESBL), metallo-β-lactamase (MBL), and AmpC β-lactamase producers, complicate treatment strategies, leading to poor patient outcomes. Infections in vulnerable patients, particularly in intensive care units (ICUs), are more susceptible to these resistant organisms, highlighting the need for urgent surveillance and effective antimicrobial strategies.

Objectives

The primary goal of this study was to assess the prevalence and antimicrobial resistance patterns of bacterial isolates from sterile body fluids, with a focus on β-lactamase-producing gram-negative bacteria. The study further aimed to highlight the implications of antimicrobial resistance patterns in guiding effective empirical therapy and infection control strategies.

Methodology

A total of 180 sterile body fluid samples, including cerebrospinal fluid (CSF), pleural fluid, pericardial fluid, bile, peritoneal or ascitic fluid, and synovial fluid, were collected and processed for bacterial isolation. Standard microbiological procedures, including Gram staining, culture on appropriate media, and biochemical identification tests, were utilized to identify the isolates, followed by antimicrobial susceptibility testing (AST) using the Kirby-Bauer disk diffusion susceptibility test to determine resistance profiles, with particular attention to ESBL, MBL, and AmpC β-lactamase production.

Results

Of the 180 samples, 27 (15%) showed bacterial growth, with Escherichia coli and Pseudomonas aeruginosa being the most frequently isolated pathogens. Testing for antimicrobial susceptibility showed notable resistance levels to commonly used antibiotics, including cefoperazone-sulbactam and piperacillin-tazobactam. ESBL production was found in 40.74% of the gram-negative isolates, and MBL production was present in 48.15%. The study recorded maximum resistance rates in CSF samples, indicating the critical need for rapid and accurate diagnostic methods. The resistance profiles of isolated pathogens revealed limited options for empirical treatment, underscoring the need for targeted antimicrobial stewardship strategies.

Conclusion

The study underscores the growing concern of multidrug-resistant gram-negative bacteria in sterile body fluid infections, particularly in vulnerable patient populations. The detection of ESBL, MBL, and AmpC-producing organisms highlights the urgency for enhanced surveillance, rapid diagnostics, and strict antimicrobial stewardship to mitigate the impact of these resistant pathogens.